Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Ecogenetics
3. Digestion of milk from the diet
4. Consequences
5. Ecogenetics of nutrition and cultural sensitivity
6. When did this mutation arise?
7. Lactose intolerance by group
8. Why does loss of lactase lead to symptoms?
9. What is the diagnosis? what is "normal"?
10. Prevention of symptoms
11. Ecogenetics: infectious agents
12. Variation in susceptibility to infections
13. Risk assessment for chemicals
14. Protecting the public from hazardous chemicals
15. Biological end-points
16. Major hazardous chemical laws in the U.S
17. Objectives of risk assessment
18. Risk assessment and management
19. Framework for regulatory decision-making
20. Data gaps: "toxic ignorance"
21. Context - comprehensive public health view
22. Context requirements
23. Toxicogenomics
24. Impetus for susceptibility analysis
25. Ecogenetic polymorphisms
26. Acetylators and bladder cancer
27. Occupational bladder cancer (Huddersfield data)
28. Susceptibility to chronic beryllium disease
29. Acetylator phenotype
30. Various risk Mgt/risk communication approaches
31. Reducing risk by orders of magnitude
32. A good advice
33. The central position of engage stakeholders

Topics Covered

• Ecogenetics of nutrition and cultural sensitivity
• Is lactose intolerance/lactase persistence a disease or an evolutionary normal variant?
• Assessment, management and communication of health risks and genetic susceptibility to environmental chemicals

Links

Series:

• Evolution and Medicine

Categories:

• Clinical Practice
• Genetics & Epigenetics

Therapeutic Areas:

• Cardiovascular & Metabolic

Talk Citation

Omenn, G. (2020, August 16). Ecogenetics, evolutionary biology and human disease [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/FODC3922.
Export Citation (RIS)

Publication History

• Published on October 1, 2007
• Reviewed on August 16, 2020

Financial Disclosures

• Prof. Gilbert Omenn has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.